These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 37520557)
1. Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2. Pichler R; Diem G; Hackl H; Koutník J; Mertens LS; D Andrea D; Pradere B; Soria F; Mari A; Laukhtina E; Krajewski W; Teoh JY; Del Guidice F; Moschini M; Thurnher M; Posch W Front Immunol; 2023; 14():1202157. PubMed ID: 37520557 [TBL] [Abstract][Full Text] [Related]
2. Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections. van Puffelen JH; Novakovic B; van Emst L; Kooper D; Zuiverloon TCM; Oldenhof UTH; Witjes JA; Galesloot TE; Vrieling A; Aben KKH; Kiemeney LALM; Oosterwijk E; Netea MG; Boormans JL; van der Heijden AG; Joosten LAB; Vermeulen SH J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36693678 [TBL] [Abstract][Full Text] [Related]
3. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques. White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S Front Immunol; 2021; 12():801799. PubMed ID: 35222355 [TBL] [Abstract][Full Text] [Related]
4. Effect of different Bacillus Calmette-Guerin substrains on growth inhibition of T24 bladder cancer cells and cytokines secretion by BCG activated peripheral blood mononuclear cells of PBMCs. Janaszek-Seydlitz W; Prygiel M; Bucholc B; Wiatrzyk A; Czajka U; Górska P; Soliwoda U Adv Clin Exp Med; 2014; 23(6):877-84. PubMed ID: 25618112 [TBL] [Abstract][Full Text] [Related]
5. Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study. Ji N; Mukherjee N; Reyes RM; Gelfond J; Javors M; Meeks JJ; McConkey DJ; Shu ZJ; Ramamurthy C; Dennett R; Curiel TJ; Svatek RS J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653802 [TBL] [Abstract][Full Text] [Related]
6. BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population. Iqbal NT; Ahmed K; Sattar T; Aziz F; Hussain R PLoS One; 2024; 19(5):e0302722. PubMed ID: 38722827 [TBL] [Abstract][Full Text] [Related]
7. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial. Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170 [TBL] [Abstract][Full Text] [Related]
8. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis? Basak P; Sachdeva N; Dayal D Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410 [TBL] [Abstract][Full Text] [Related]
9. Evidence of innate training in bovine γδ T cells following subcutaneous BCG administration. Samuel BER; Diaz FE; Maina TW; Corbett RJ; Tuggle CK; McGill JL Front Immunol; 2024; 15():1423843. PubMed ID: 39100669 [TBL] [Abstract][Full Text] [Related]
10. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients. Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445 [TBL] [Abstract][Full Text] [Related]
11. Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults. Rakshit S; Adiga V; Ahmed A; Parthiban C; Chetan Kumar N; Dwarkanath P; Shivalingaiah S; Rao S; D'Souza G; Dias M; Maguire TJA; Doores KJ; Zoodsma M; Geckin B; Dasgupta P; Babji S; van Meijgaarden KE; Joosten SA; Ottenhoff THM; Li Y; Netea MG; Stuart KD; De Rosa SC; McElrath MJ; Vyakarnam A Front Immunol; 2022; 13():985938. PubMed ID: 36268023 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy. Akan S; Ediz C; Kızılkan YE; Alcin A; Tavukcu HH; Yilmaz O Int J Clin Pract; 2021 Mar; 75(3):e13752. PubMed ID: 33064918 [TBL] [Abstract][Full Text] [Related]